Please login to the form below

Not currently logged in
Email:
Password:

Duchenne muscular distrophy

This page shows the latest Duchenne muscular distrophy news and features for those working in and with pharma, biotech and healthcare.

NICE backs PTC's muscular dystrophy drug Translarna

NICE backs PTC's muscular dystrophy drug Translarna

Duchenne muscular dystrophy (DMD) patients and their families have welcomed a decision by NICE making PTC Therapeutics' Translarna available on the NHS. ... The Muscular Dystrophy UK charity described the decision as 'history in the making', and welcomed

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics